2nd Quarter - Report

THORN RUN PARTNERS for HARMONY BIOSCIENCES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the development of therapies for rare diseases. Issues regarding drug pricing.

LobbyistCovered position, as disclosed
ANDREW ROSENBERG —
BEAU SCHUYLER Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to the orphan drug tax credit. Issues related to the Prescription Drug User Fee Act (PDUFA). Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.

LobbyistCovered position, as disclosed
ANDREW ROSENBERG —
BEAU SCHUYLER Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S.Con.Res. 14 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.